Cytek Biosciences (CTKB) Change in Acquisitions & Divestments (2023 - 2026)

Cytek Biosciences (CTKB) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $70.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments changed 0.4% year-over-year to $70.7 million; the trailing twelve-month figure through Mar 2026 stood at $292.5 million (up 51.21% YoY), and the FY2025 full-year result was $292.2 million, up 49.85% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $70.7 million, down from $76.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $79.2 million in Q3 2025 and bottomed at $10.0 million in Q2 2023.
• The 4-year median for Change in Acquisitions & Divestments is $67.2 million (2023), against an average of $57.5 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 300.0% in 2024, while the deepest fall reached 44.12% in 2024.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $54.0 million in 2023, then retreated by 16.67% to $45.0 million in 2024, then soared by 69.12% to $76.1 million in 2025, then fell by 7.08% to $70.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $70.7 million (Q1 2026), $76.1 million (Q4 2025), and $79.2 million (Q3 2025), per Business Quant data.

Peer Comparison